We are live on ! Find out more
ETM

Euclidean Technologies Management Portfolio holdings

AUM $109M
1-Year Est. Return 7.18%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+7.18%
3 Year Est. Return
+123.73%
5 Year Est. Return
+76.06%
10 Year Est. Return
AUM
$125M
AUM Growth
+$10.5M
Cap. Flow
+$7.47M
Cap. Flow %
5.96%
Top 10 Hldgs %
23.54%
Holding
104
New
35
Increased
23
Reduced
10
Closed
9

Top Sells

Rank Stock Value
1
MED icon
Medifast
MED
+$3.6M
2
SMCI icon
Super Micro Computer
SMCI
+$2.93M
3
OSK icon
Oshkosh
OSK
+$2.65M
4
MTH icon
Meritage Homes
MTH
+$1.93M
5
ANIK icon
Anika Therapeutics
ANIK
+$1.83M

Sector Composition

Rank Sector Weight
1 Industrials 38.86%
2 Consumer Discretionary 19.96%
3 Consumer Staples 13.12%
4 Technology 10.18%
5 Healthcare 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSK icon
101
Oshkosh
OSK
$8.96B
-22,328
Closed -$2.65M
SCS
102
DELISTED
Steelcase
SCS
-10,420
Closed -$150K
SMCI icon
103
Super Micro Computer
SMCI
$15.6B
-749,940
Closed -$2.93M
UTHR icon
104
United Therapeutics
UTHR
$22.7B
-1,270
Closed -$212K

Similar funds

Euclidean Technologies Management's Q2 2021 Portfolio in Review

As of Q2 2021, Euclidean Technologies Management held 104 positions worth $125M, up 9.2% from $115M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Euclidean Technologies Management deployed $7.47M of net new capital in Q2 2021, opening 35 new positions and adding to 23 existing holdings. Its largest new stake was Perdoceo Education: 211,239 shares worth $2.59M.

By sector, the portfolio is most concentrated in Industrials at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Shoe Station Group, an estimated $1.42M trimmed.

  • Euclidean Technologies Management's largest Q2 2021 buy was Perdoceo Education: 211,239 shares worth $2.59M.
  • Euclidean Technologies Management added most to MarineMax in Q2 2021, an estimated $2.71M increase.
  • Euclidean Technologies Management's biggest Q2 2021 reduction was Shoe Station Group, cutting an estimated $1.42M.
  • Euclidean Technologies Management fully exited Medifast in Q2 2021, selling an estimated $3.6M.
  • Euclidean Technologies Management's ten largest holdings make up 24% of its $125M portfolio in Q2 2021.
  • Euclidean Technologies Management opened 35 new positions and closed 9 in Q2 2021.
  • Euclidean Technologies Management's portfolio value rose 9.2% quarter-over-quarter to $125M.

Based on Euclidean Technologies Management's 13F filing for Q2 2021, filed 5 Aug 2021.